A team of Collins & Jones lawyers represented the shareholders of National Enzyme Company (NEC) in the sale of the stock of NEC to Chicago-based private equity firms Prairie Capital and Skyline Global Partners.

NEC was founded in 1932 and is based in Forsythe, Missouri. The company is the leading manufacturer of specialty enzymes for the digestive health market, both in the United States and internationally.

The financial terms of the transaction were not disclosed. Josh Jones, Eric Collins and Kerry Morgan lead our team’s work on this large, complex transaction.

Alex Bertz Joins Collins & Jones

by | Oct 7, 2025 |

Collins & Jones is pleased to announce that Alex Bertz has joined the Firm as an associate attorney, practicing in the areas of general and corporate business, estate planning, and tax law. Alex grew up in Lee’s Summit, Missouri. He attended the University of...

read more

Kerry Morgan Makes Shareholder

by | Jan 20, 2025 |

Collins & Jones is pleased to announce its newest shareholder, Kerry Morgan, effective January 1, 2025. Kerry has been with Collins & Jones since 2014 when she started as a law clerk. Following graduation from UMKC Law School in 2015, Kerry became an associate...

read more

Recent Posts

Past results do not guarantee future results. Every case and matter is different and should be judged on its own merits. The choice of a lawyer is an important decision and should not be based solely upon advertisements. The information you obtain at this site is not, nor is it intended to be, legal advice.

CONTACT US

RAYMORE
OFFICE

Phone: 816-318-9966
Fax: 888-376-8024

OSCEOLA
OFFICE

Phone: 417-646-2245
Fax: 888-463-4813